CIK 1005201

Assertio Therapeutics, Inc

EDGAR filings

Customers

2 disclosed

Suppliers

None disclosed

Largest customer

16%

MCK · FY to 2019-12-31

Named-customer revenue

$59.7M

2 customers · FY to 2019-12-31

Latest period

Dec 31, 2019

10-K filed 2020-03-10

Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available) or federal dollars obligated. Each side is scaled on its own; dashed outlines are named without a figure. Click a band to open its source.

Customers 2

Companies Assertio Therapeutics, Inc discloses as major customers, as a share of Assertio Therapeutics, Inc revenue. 2 active, 0 lapsed.

Company	% of Assertio Therapeutics, Inc revenue	Est. revenue	Period	Trend	Status	Source
MCK Distributor MCKESSON CORP	16%	$36.7M	FY 2019-12-31	+2.0pp	Active	10-K 2020-03-10
McKesson Corporation 16 % 14 % 36 % 46 % 28 % 41 % 10-K filed 2020-03-10 Period FY 2019-01-01 to 2019-12-31 (16%), FY 2018-01-01 to 2018-12-31 (14%), FY 2017-01-01 to 2017-12-31 (36%)Accession 0001005201-20-000021 McKesson Corporation 14 % 36 % 36 % 28 % 41 % 39 % 10-K filed 2019-03-11 Period FY 2016-01-01 to 2016-12-31 (36%)Accession 0001005201-19-000040
CAH Distributor CARDINAL HEALTH INC	10%	$23.0M	FY 2019-12-31	−1.0pp	Active	10-K 2020-03-10
Cardinal Health 10 % 11 % 26 % 25 % 32 % 23 % 10-K filed 2020-03-10 Period FY 2019-01-01 to 2019-12-31 (10%), FY 2018-01-01 to 2018-12-31 (11%), FY 2017-01-01 to 2017-12-31 (26%)Accession 0001005201-20-000021 Cardinal Health 11 % 26 % 25 % 32 % 23 % 20 % 10-K filed 2019-03-11 Period FY 2016-01-01 to 2016-12-31 (25%)Accession 0001005201-19-000040

Unnamed major customers

Disclosed without names in the fiscal year ending 2019-12-31. Identities are not inferred.

All Other10%

Alerts are coming

Get an email when Assertio Therapeutics, Inc's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.